Volume 3, Number 1, January-February-March 2010

Making sense of HDL cholesterol
Jonathan Morrell

Lowering LDL cholesterol (LDL-C) with statins for the prevention of cardiovascular disease (CVD) has rightly become a core activity in primary care. However, recognising that the benefits of reducing LDL-C with statins are limited has led to the recognition that the ‘residual risk’ that remains may be modified further by attention to other lipoprotein fractions, particularly HDL cholesterol (HDL-C).

View full PDF article (open in new window)
Email this article

Right click on this DOI link and copy link to cite this article (What is a DOI link?)